Table 2

Patient characteristics

RISTaCSTb
Total number1619
Age, median (range)51.5 (15–66)41 (18–51)
Sex (F/M)5/1111/8
Disease
AML/MDSc6/65/1
ALL/NHL0/24/3
CML26
HLA
6/61218
5/641
  • a In the RIST group, ATG was administered 4 days in six patients, 2 days in eight patients, and 0 days in two.

  • b In the CST group, 9 received busulfan/cyclophosphamide and 10 received cyclophosphamide/total body irradiation.

  • c MDS, myelodysplastic syndrome; ALL, acute lymphoblastic leukemia; CML, chronic myeloid leukemia.